Head-To-Head Analysis: Sanara MedTech (SMTI) and Its Rivals

Sanara MedTech (NASDAQ:SMTI) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare Sanara MedTech to similar companies based on the strength of its earnings, analyst recommendations, profitability, valuation, dividends, risk and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and target prices for Sanara MedTech and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanara MedTech	1	4	0	0	1.80
Sanara MedTech Competitors	4288	10570	18345	830	2.46

Sanara MedTech currently has a consensus price target of $35.00, suggesting a potential upside of 10.55%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.22%. Given Sanara MedTech’s peers stronger consensus rating and higher possible upside, analysts clearly believe Sanara MedTech has less favorable growth aspects than its peers.

Volatility & Risk

Sanara MedTech has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Sanara MedTech’s peers have a beta of 2.57, meaning that their average share price is 157% more volatile than the S&P 500.

Profitability

This table compares Sanara MedTech and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sanara MedTech	-29.15%	29.72%	2.84%
Sanara MedTech Competitors	-304.10%	-178.81%	-22.11%

Institutional and Insider Ownership

8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 42.0% of Sanara MedTech shares are held by insiders. Comparatively, 15.0% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Sanara MedTech and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sanara MedTech	$103.12 million	-$37.56 million	-8.82
Sanara MedTech Competitors	$1.89 billion	$136.85 million	12.52

Sanara MedTech’s peers have higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Sanara MedTech peers beat Sanara MedTech on 8 of the 13 factors compared.

About Sanara MedTech

Sanara MedTech Inc. is a medical technology company focused on developing, commercializing and distributing products used in wound care, surgical soft-tissue repair and tissue regeneration. The company serves healthcare providers treating acute, chronic and complex wounds, as well as patients requiring surgical tissue management. Sanara’s product portfolio includes advanced wound-care and tissue-repair technologies such as CellerateRX products, FORTIFY tissue-repair products and other regenerative medicine solutions.